We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between January and March 2016 (quarter 4).
Details of PHE's government procurement card expenditure over £500.
Details of Public Health England transactions over £25,000 in June 2016.
Details of Public Health England transactions over £25,000 in May 2016.
Details of Public Health England transactions over £25,000 in April 2016.
Published every 3 months.
The Human Fertilisation and Embryology Authority (HFEA) annual report and accounts 2015 to 2016.
Public Health England's (PHE) annual report and accounts has been laid before Parliament today (21 July 2016).
The agenda and papers available for the Public Health England Board meeting of 20 July 2016.
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
This report summarises the work of the UK National Screening Committee (UK NSC) to review screening recommendations from 1 April 2015 to 31 March 2016.
Describes the terms of reference for the PHE Cancer Board, including details of its purpose, membership and responsibilities.
Annual report and accounts from the Human Tissue Authority (HTA), covering 1 April 2015 to 31 March 2016.
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
This document outlines the code of conduct that all Public Health England (PHE) staff must abide by.
Report outlining the Medicines and Healthcare products Regulatory Agency’s (MHRA's) commitment to burden reduction activity.
The agenda and papers available for the Public Health England Board meeting of 25 May 2016.
This register of interests records those interests that members of PHE committee's hold outside the agency.
Letter from Jane Ellison MP confirming the role the government expects PHE to play in the health and care system in 2016 to 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).